ClinicalTrials.Veeva

Menu

Incidence and Management of Ocular Hypertension Following Deep Anterior Lamellar Keratoplasty (Dalk)

M

Mansoura University

Status

Unknown

Conditions

Unrecognized Condition

Treatments

Other: antiglaucoma

Study type

Observational

Funder types

Other

Identifiers

NCT04931316
R.20.12.1121

Details and patient eligibility

About

This is a retrospective case series study that included patients who performed deep anterior lamellar keratoplasty and presented with elevated intraocular pressure during follow up.

Full description

This is a retrospective case series study that included patients who performed deep anterior lamellar keratoplasty and presented with elevated intraocular pressure during follow up. Patients' demographic characteristics, medical, and ocular history will be recorded.

Inclusion criteria will include patients who were diagnosed with elevated intraocular pressure (IOP) after DALK surgery performed from 2018 to 2020 with follow up duration more than 6 months. Patients with less than 6 months of follow-up will be excluded from the study.

Patients' demographic characteristics, medical and ocular history will be recorded. Baseline complete ophthalmic examination was performed. It included best corrected visual acuity (BCVA) using Landolt C chart that was converted to log minimum angle of resolution (log MAR) for statistical analysis, slit lamp anterior segment examination (with attention to cornea, bulbar conjunctiva and AC), intraocular pressure measurement using rebound system (I care tonometer, Topcon, Canada), angle assessment and fundus examination using Goldman 3 mirror contact lens.

High IOP was defined as intraocular pressure more than 25 mmHg. Data will be collected with attention to appropriate management done either medical treatment or surgical intervention.

Enrollment

10 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who were diagnosed with elevated IOP after DALK surgery performed from 2018 to 2020

Exclusion criteria

  • Patients with penetrating keratoplasty

Trial contacts and locations

1

Loading...

Central trial contact

Aya Hashish, MD; Amgad El Nokrashy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems